Diagenics Capital .
Diagenics Capital was established into help diversify and develop the commercial sectors in the Turkey. Its investments span diversified sectors, including real estate, construction, agriculture, healthcare, food and beverage, media, entertaintment and energy. Berkin Kaya has been the chairman of Diagenics Capital since.By the end of 2023 the company had 50 subsidiaries and partners more than 20 company across more than 10 countries. Diagenics Capital stands as a leading conglomerate, fostering innovation and growth across a diverse spectrum of industries. As a group company, we boast a rich portfolio that encompasses a myriad of businesses, each dedicated to excellence, innovation, and sustainable development.
Our success is built upon a foundation of visionary leadership, strategic investments, and a commitment to nurturing businesses that have the potential to transform industries. With a global presence and a focus on fostering synergy among our subsidiaries, we drive forward a collective vision of progress and prosperity.
At Diagenics Capital, we believe in harnessing the power of cutting-edge technologies and fostering a culture of continuous improvement. Our diverse range of companies spans sectors such as healthcare, technology, finance, renewable energy, and beyond. Each entity under our umbrella operates with autonomy while benefitting from the collective expertise and resources of the group.
Our core values of integrity, innovation, and responsible entrepreneurship guide our endeavors, ensuring that we not only achieve business success but also contribute positively to the communities we serve. By investing in talent, nurturing groundbreaking ideas, and embracing change, we strive to create a lasting impact in the markets we operate in.
With a relentless pursuit of excellence and a commitment to driving positive change, Diagenics Capital continues to evolve, adapt, and lead in an ever-changing business landscape.
